Prevalence, molecular characterization, and prognosis of c-Met protein overexpression in a real-world cohort of patients with non-squamous non-small cell lung cancer.

Furthermore, we observed a positive trend in c-Met protein OE positivity from low to high PD-L1, supporting the rationale of investigating c-Met protein–targeting ADCs in combination with PD-1/PD-L1 inhibitors for these tumors.

also in 11,005 other papers